Bell Potter says this ASX 200 share can rise 50%

The broker thinks this stock is being seriously undervalued by the market.

| More on:
A man clenches his fists in excitement as gold coins fall from the sky.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Bell Potter sees significant upside in Nufarm shares, citing strong FY26 EBITDA growth potential and improved debt positions as key factors.
  • Nufarm's FY25 results met expectations, with a focus on growth in crop protection and seed technologies, poised for continued momentum in FY26.
  • Bell Potter has issued a buy rating with a $3.60 price target, suggesting a potential 52% return over the next year, alongside expected dividend yields growing to 3% by FY28.

Nufarm Ltd (ASX: NUF) shares could be an ASX 200 share to buy right now.

That's the view of analysts at Bell Potter, which see significant upside potential for the agricultural company's shares.

What is the broker saying about this ASX 200 share?

Bell Potter highlights that Nufarm released its results this week and delivered numbers that were in line with expectations and its guidance. It said:

Revenue of $3,443m was up +3% YOY (vs. BPe $3,464m). Operating EBITDA of $302.1m was up down -3% YOY (BPe $302.5m and implied guidance of $283-308m). Operating NPAT loss of -$22.9m compares to a -$3.7m loss in FY24 (and vs. BPe -$9.4m). Hybrid Seeds generated EBITDA of $67m (vs. $74m FY24) and the emerging seed platforms incurred a loss of -$53m (-$11m loss in FY24) inclusive of $29m in inventory impairments and ~$20m in operating losses in omega-3.

It was also pleased to see that Nufarm's debt had reduced to $824.2 million at the end of FY 2025, which was better than its guidance of $850 million to $925 million.

Looking ahead, the broker points out that management is guiding to EBITDA growth in FY 2026.

Key comments: (1) Expect strong FY26e underlying EBITDA growth under normal conditions; (2) Crop protection EBITDA continuing to grow, moderating on the +18% YOY growth in FY25; (2) Seed technologies growth in EBITDA from hybrid Seed and targeting a $30m YOY improvement in the emerging platforms; and (4) Expect positive free cashflow in FY26e and net debt/EBITDA of ~2.0x (vs. 2.7x in FY25).

Big return potential

In response to the results, Bell Potter has retained its buy rating on the ASX 200 share with an improved price target of $3.60.

Based on the current Nufarm share price of $2.37, this implies potential upside of 52% for investors over the next 12 months.

To put that into context, a $10,000 investment would turn into over $15,000 by this time next year if Bell Potter is on the money with its recommendation.

In addition, the broker is expecting a modest 1.3% dividend yield in FY 2026, and then 2.1% in FY 2027 and 3% in FY 2028.

Commenting on its buy recommendation, Bell Potter said:

NUF delivered a FY25 result modestly ahead of consensus, driven by +170bp topline outperformance in Crop protection revenue growth (relative to sector aggregates) and highlighted by a better-than-expected net debt position. In recent weeks we have witnessed a strengthening in omega-3 oil pricing indicators (following the IMARPE catch quota) while also noting continued YOY growth in active ingredient values.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

gold share price represented by speeding golden bullet
Broker Notes

Why this surging ASX All Ords gold stock is tipped to rocket another 233%

A leading broker expects outsized gains from this ASX All Ords gold stock. But not without risk.

Read more »

Engineer at an underground mine and talking to a miner.
Opinions

Best ASX mining stock to buy right now: Fortescue or South32?

Here’s my pick between the two mining majors.

Read more »

A blockchain investor sits at his desk with a laptop computer open and a phone checking information from a booklet in a home office setting.
Broker Notes

3 buy-rated ASX 300 shares at 52-week lows

They've fallen far over the past 12 months but have buy ratings from the experts.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Broker Notes

Bell Potter names more of the best ASX 200 shares to buy in December

These are best buys according to the broker. Here's what it is saying about them.

Read more »

Man with his head on his head with a red declining arrow and A worried man holds his head and look at his computer as the Megaport share price crashes today
Share Fallers

Why is the Bapcor share price crashing 19% on Tuesday?

Investors are punishing Bapcor shares today. But why?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

woman on phone
Communication Shares

Up 24% in a year! The red-hot Telstra share price is smashing BHP, Westpac and Coles

The Aussie telco's shares stormed higher over the past 12 months.

Read more »

Two company members shaking hands on a deal.
Share Market News

Liontown clinches Canmax deal: key details for investors

Liontown has struck an offtake deal with Canmax for its spodumene concentrate, bolstering customer diversification plans.

Read more »